Catherine (Cat) Jennings leads the Peripheral Vascular business at Boston Scientific. In her role, she is responsible for developing and bringing to market peripheral vascular technologies and innovative solutions that treat peripheral arterial and venous disease. Prior to this role, Cat served as VP of Marketing and New Business Development and GM of Varithena within Peripheral Interventions. Since joining Guidant/Boston Scientific in 2004, she has held multiple marketing and strategy roles in both the Rhythm Management and Peripheral Interventions business units.
Cat holds an MBA from the UCLA Anderson School of Management and a BS in Biology from Georgetown University. Cat resides in Minneapolis, MN, with her husband Jason and their two children.